Fundraising Fox

David Allison

Investor

Managing Director at Westlake Village BioPartners · Board director at Soteria Biotherapeutics

San Francisco Bay Area

Writes $100K – $5M checks · typically $1.5M

About

Managing Director with over 15 years in healthcare investing, company formation, and translational research; previously a partner at 5AM Ventures and on investment teams at Versant Ventures, Split Rock Partners, and PTV Healthcare Capital. Holds a PhD in Bioengineering from Rice University.

Contact· self-published, not guessed

Board director at Soteria Biotherapeutics

Intro paths

In turn, David can intro founders to Soteria Biotherapeutics's investors below.

Experience

  1. Westlake Village BioPartners®Managing Directorcurrent2023 — presentSan Francisco Bay Area
  2. Borealis Biosciences, Inc.Board Membercurrent2024 — presentVancouver, British Columbia, Canada
  3. Latigo Biotherapeutics, Inc.Board Member (Observer)current2023 — presentLos Angeles, California, United States
  4. Recludix PharmaBoard Membercurrent2023 — presentSan Diego, California, United States
  5. AllRock BioBoard Membercurrent2023 — presentBoston, Massachusetts, United States
  6. Neurogastrx, Inc.Board Member2017 — 2025Boston, Massachusetts, United States
  7. Impel PharmaceuticalsBoard Member2016 — 2024Seattle, Washington, United States
  8. Radionetics OncologyBoard Member2021 — 2023San Diego, California, United States
  9. InipharmBoard Member (Observer)2020 — 2023San Diego, California, United States
  10. Magnetic Insight, IncBoard Member2017 — 2023Alameda, California, United States
  11. 5AM VenturesPartner2016 — 2023San Francisco Bay Area
  12. Portal InstrumentsBoard Member2016 — 2023Boston, Massachusetts, United States
  13. CinCor Pharma, Inc.Board Member2019 — 2023Boston, Massachusetts, United States
  14. Crinetics PharmaceuticalsBoard Member (Observer)2015 — 2018
  15. Versant VenturesPrincipal2014 — 2016San Francisco, CA
  16. Split Rock PartnersPrincipal2009 — 2014Menlo Park, CA
  17. PTV Healthcare CapitalSenior Associate2006 — 2009Austin, Texas
  18. SurModicsResearch and Development Engineer2004Eden Prairie, MN
  19. Cleveland ClinicNSF Research Fellow2002Cleveland, Ohio

Skills & more

Strategy7Management4Strategic Planning2Venture Capital18Biotechnology13Life Sciences17Lifesciences12Start-ups4Biomaterials11Due Diligence9Product Development4Entrepreneurship3
+3 moreMergers & AcquisitionsResearch and Development (R&D)Business Development

From David's professional profile.

Deals · 4

Arpeggio BioBoard seat

via Westlake Village BioPartners · filed Nov 2025 · $35.3M raise

NeurogastrxBoard seat

via Westlake Village BioPartners · filed Jul 2021

Soteria BiotherapeuticsBoard seat

via Westlake Village BioPartners · filed May 2021 · $42.2M raise

Impel NeuropharmaBoard seat

via Westlake Village BioPartners · filed Apr 2021 · $1.9M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Westlake Village BioPartners

Network5

Investors connected to David in public investor directories — a warm-intro map.

Frequently asked questions

Who is David Allison?
Managing Director with over 15 years in healthcare investing, company formation, and translational research; previously a partner at 5AM Ventures and on investment teams at Versant Ventures, Split Rock Partners, and PTV Healthcare Capital. Holds a PhD in Bioengineering from Rice University.
Where does David Allison work?
David Allison is Managing Director at Westlake Village BioPartners and Board director at Soteria Biotherapeutics.
What check size does David Allison write?
David Allison typically writes checks of $100K – $5M.
What boards does David Allison sit on?
David Allison holds tracked board seats at Arpeggio Bio, Impel Neuropharma, Neurogastrx, Soteria Biotherapeutics.
Where did David Allison go to school?
David Allison studied at Rice University (Ph.D., Bioengineering); University of Iowa (BSE, Biomedical Engineering).

Same school

Shared employers